Things You Need to Know About Acomplia

Monaslim, Remonabent, Zimulti, Slimona, Rimoslim and Rimonabant are just some of the trade names of Acomplia. Today, this is possibly the most controversial drug in the pharmaceutical industry, worldwide.

What is Acomplia?
Acomplia is an anti-obesity drug manufactured by Sanofi-Aventis. It works by blocking the receptors in the brain, which control food and nicotine intake. The drug is taken by people who have more than 30% BMI, while members of the medical profession advise that it should only be taken as part of a healthy diet and exercise regime.

What are its other uses?
Apart from weight loss, Acomplia is also prescribed as an aid to stopping smoking. Many who quit smoking find that they gain weight, which is where Acomplia helps. Studies show that Acomplia can also help prevent addiction and drug addicts who have gone through rehab find they do not relapse when treated with Acomplia. However, the effectiveness of Acomplia as an anti drug addiction treatment has not been studied in as much detail as it has in connection with that of smoking.

What are its side effects?
Reports have found that patients who used Acomplia suffered from several mental disorders, such as depression and anxiety, while others reported having suicidal thoughts. Anyone taking Acomplia has a higher risk of developing neurodegenerative diseases like Parkinson’s, Huntington’s, Alzheimer’s or multiple sclerosis. It is believed that the manufacturer may not have fully disclosed the side effects of the drug when it was originally released.

Though some of the side effects are mild, many who used Acomplia have since stopped using the drug due to a fear of unknown long-term side effects.

Today, Acomplia has been withdrawn from the global market, though it can still be obtained online, illegally. Researchers are now studying Acomplia in greater detail than ever before.